Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05471934
Other study ID # LRP14011-CICAPLAST BAUME B5
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 2014
Est. completion date May 2014

Study information

Verified date July 2022
Source Cosmetique Active International
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The participants presenting with hand problems and meeting the inclusion criteria are asked to apply the study product for one month. They are evaluated before and after treatment.


Description:

The international, open, observational survey is conducted in 3 different countries. Regarding the statistical analysis, the global satisfaction is described in 5 classes and in 2 classes "Satisfied + Very satisfied" vs. "Neither satisfied nor dissatisfied + Not so satisfied + Not at all satisfied". The 95% Confidence Interval (CI) of the percent of "Satisfied + Very satisfied" is also given. On patients who already used cream at the inclusion, the following analyses are performed: - Cross-tabulation between both visits, - Test of the evolution between both visits using a special procedure for ordinal data with repeated measures, - Description of a summary variable in 3 classes (Improved / No change / Worsened). For the analysis of the hands problems, each sign is described at the inclusion and at the evaluation visit. The difference Evaluation-Inclusion is also given. The evolution of the sign is performed by a Wilcoxon test for matched samples.


Recruitment information / eligibility

Status Completed
Enrollment 380
Est. completion date May 2014
Est. primary completion date May 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - professionals that work on different activities related to hair in a beauty salon - professionals presenting with current hand problems such as dryness, redness, irritations, cracks and fissures Exclusion Criteria: - professionals that do not meet the inclusion criteria

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Italy Dermatology practices Roma
Poland Dermatology practices Warsaw
Slovenia Dermatology practices Ljubljana

Sponsors (1)

Lead Sponsor Collaborator
Cosmetique Active International

Countries where clinical trial is conducted

Italy,  Poland,  Slovenia, 

Outcome

Type Measure Description Time frame Safety issue
Primary satisfaction rate satisfaction questionnaire with a 5-point scale from baseline to Day28
Secondary evaluation of hands problems (dryness, redness, irritations, cracks, fissures) evaluation on a 10-point scale (0 Not at all to 10 Very strong) from baseline to Day28
See also
  Status Clinical Trial Phase
Completed NCT00576550 - A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema Phase 4
Completed NCT00404196 - LEO19123 Cream in the Treatment of Hand Eczema Phase 2
Completed NCT05763914 - A 24-week Single-blind Trial of Prevention of Hand Eczema in Cleaners N/A
Recruiting NCT03026946 - Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema Phase 3
Recruiting NCT03026907 - Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema Phase 3
Completed NCT00488241 - Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema Phase 4
Active, not recruiting NCT05906628 - Topical Ruxolitinib Evaluation in Chronic Hand Eczema Phase 2
Terminated NCT01826630 - A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema N/A
Recruiting NCT04449575 - Hand Eczema in the Health Care Sector
Withdrawn NCT05219864 - Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1 Phase 3
Completed NCT01591785 - Treatment of Staphylococcus Aureus Colonization in Hand Eczema N/A
Completed NCT00826592 - Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis N/A
Completed NCT02664805 - Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema Phase 2
Active, not recruiting NCT04512339 - Dupilumab in Severe Chronic Hand Eczema Phase 2
Completed NCT04375410 - Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic